ACAD
Acadia Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$20.61
-0.66 ▼ -3.10%
🌙 3월 13일 7:44 PM ET (한국 3/14 08:44)
$20.52
-0.09 ▼ -0.44%
| Index | RUT | P/E | 9.01 | EPS (ttm) | 2.29 | Insider Own | 1.51% | Shs Outstand | 0.17B | Perf Week | -6.99% |
| Market Cap | 3.51B | Forward P/E | 24.26 | EPS next Y | 88.76% | Insider Trans | -2.08% | Shs Float | 0.17B | Perf Month | -8.28% |
| Enterprise Value | 2.75B | PEG | - | EPS next Q | 0.06 | Inst Own | 97.14% | Short Float | 5.65% | Perf Quarter | -23.13% |
| Income | 0.39B | P/S | 3.28 | EPS this Y | -80.44% | Inst Trans | -1.66% | Short Ratio | 6.32 | Perf Half Y | -14.83% |
| Sales | 1.07B | P/B | 2.86 | EPS next 5Y | -11.87% | ROA | 28.42% | Short Interest | 9.49M | Perf YTD | -22.84% |
| Book/sh | 7.21 | P/C | 4.29 | EPS past 3/5Y | - | ROE | 39.89% | 52W High | -27.3% ($28.35) | Perf Year | 22.82% |
| Cash/sh | 4.81 | P/FCF | 33.42 | Sales past 3/5Y | 27.48% 19.39% | ROIC | 30.84% | 52W Low | 53.81% ($13.40) | Perf 3Y | 6.18% |
| Dividend Est. | - | EV/EBITDA | 23.56 | EPS Y/Y TTM | 69.77% | Gross Margin | 91.69% | Volatility(W/M) | 3.85% 4.52% | Perf 5Y | -23.78% |
| Dividend TTM | - | EV/Sales | 2.56 | Sales Y/Y TTM | 11.87% | Oper. Margin | 9.78% | ATR (14) | 1.01 | Perf 10Y | 2.08% |
| Dividend Ex-Date | - | Quick Ratio | 3.71 | EPS Q/Q | 85.14% | Profit Margin | 36.49% | RSI (14) | 31.54 | Recom | 1.71 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.83 | Sales Q/Q | 9.39% | SMA20 | -10.82% ($23.11) | Beta | 0.85 | Target Price | $31.85 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2000000 | SMA50 | -16.28% ($24.62) | Rel Volume | 1.03 | Prev Close | $21.27 |
| Employees | 798 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | 1067.88% -3% | SMA200 | -13.32% ($23.78) | Avg Volume(3M) | 1.50M | Price | $20.61 |
| IPO | 2004/5/27 | Option/Short | Yes/Yes | Trades | 17033 | Volume | 1,553,287 | Change | -3.1% |
뉴스 로딩 중...